Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis

被引:12
|
作者
Alosaimi, Fahad D. [1 ]
AlMulhem, Alaa [2 ]
AlShalan, Hanan [2 ]
Alqazlan, Mohammad [3 ]
Aldaif, Abdulgader [4 ]
Kowgier, Matthew [5 ]
Balasundaram, Janooshsheya [6 ]
Sockalingam, Sanjeev [6 ,7 ]
机构
[1] King Saud Univ, Dept Psychiat, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Med Hlth, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Univ Hlth Network, Ctr Mental Hlth, Toronto, ON, Canada
[7] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
来源
关键词
multiple sclerosis; adherence; depression; attachment style; culture; MORTALITY; SEVERITY; DEPRESSION; PREVALENCE; VALIDITY; CARE; TOOL;
D O I
10.2147/PPA.S129678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culturespecific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. Methods: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. Results: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%+/- 25.26%. Multivariate linear regression analysis only identified patients' belief that their MS was due to "supernatural" forces as being significantly negatively associated with MS medication adherence. Conclusion: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
  • [11] Patient choice and adherence with disease-modifying therapy in multiple sclerosis
    Burke, G
    Pozo, A
    Nairne, A
    Birmingham, H
    Gregory, R
    Palace, JA
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S189 - S189
  • [12] Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
    Talente, Bari
    Finseth, Lisbet
    Blake, Natalie
    Costello, Kathleen
    Schmidt, Hollie
    Vandigo, Joe
    Oehrlein, Elisabeth M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2025, 17 : 199 - 215
  • [13] Adherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosis
    Ozura, Ana
    Kovac, Lea
    Sega, Sasa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S6 - S11
  • [14] Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
    Burkhard, Adam
    Toliver, Joshua
    Rascati, Karen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 915 - 923
  • [15] Discontinuing disease-modifying multiple sclerosis therapies
    Krysko, Kristen
    LANCET NEUROLOGY, 2023, 22 (07): : 543 - 545
  • [16] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    NEUROLOGY, 2015, 84 (21) : E181 - E185
  • [17] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [18] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [19] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [20] Update on disease-modifying therapies for multiple sclerosis
    Vargas, Diana L.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891